About Michael Artinger
Form D filings for Solaris Vaccines from 2022 to 2023 list Michael Artinger as CEO and director.
Michael Artinger first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Artinger in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Artinger works with at each company, as listed on that company's latest Form D.
Solaris Vaccines, Inc. · Form D, May 19, 2023
RG
Robert Goforth
Director